Blueprint Medicines (BPMC)
(Delayed Data from NSDQ)
$113.69 USD
-1.29 (-1.12%)
Updated Jul 25, 2024 04:00 PM ET
After-Market: $113.60 -0.09 (-0.08%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO8/1/24 |
---|---|
Current Quarter | -1.27 |
EPS Last Quarter | -1.32 |
Last EPS Surprise | 19.51% |
ABR | 1.76 |
Earnings ESP
|
2.78% |
---|---|
Current Year | -2.01 |
Next Year | -2.19 |
EPS (TTM) | -7.53 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 104.55M | 114.69M | 439.27M | 657.31M |
# of Estimates | 9 | 9 | 9 | 9 |
High Estimate | 112.00M | 132.20M | 494.10M | 964.00M |
Low Estimate | 98.08M | 103.33M | 409.53M | 590.86M |
Year ago Sales | 57.57M | 56.57M | 249.38M | 439.27M |
Year over Year Growth Est. | 81.61% | 102.74% | 76.14% | 49.64% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.27 | -1.11 | -2.01 | -2.19 |
# of Estimates | 10 | 9 | 8 | 11 |
Most Recent Consensus | -1.30 | -1.22 | -2.10 | -2.77 |
High Estimate | -1.10 | -0.87 | -1.10 | 1.71 |
Low Estimate | -1.43 | -1.25 | -2.59 | -3.98 |
Year ago EPS | -2.19 | -2.20 | -8.37 | -2.01 |
Year over Year Growth Est. | 42.01% | 49.55% | 75.99% | -8.98% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 2 | 1 | 1 | 1 |
Up Last 30 Days | 3 | 2 | 2 | 2 |
Up Last 60 Days | 3 | 2 | 2 | 2 |
Down Last 7 Days | 0 | 1 | 0 | 1 |
Down Last 30 Days | 0 | 1 | 1 | 1 |
Down Last 60 Days | 0 | 1 | 1 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.27 | -1.11 | -2.01 | -2.19 |
7 Days Ago | -1.29 | -1.13 | -2.06 | -2.22 |
30 Days Ago | -1.30 | -1.14 | -2.45 | -2.25 |
60 Days Ago | -1.30 | -1.14 | -2.43 | -2.07 |
90 Days Ago | -1.42 | -1.25 | -5.48 | -2.89 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.24 | -1.13 | -1.99 | -2.21 |
Zacks Consensus Estimate | -1.27 | -1.11 | -2.01 | -2.19 |
Earnings ESP | 2.78% | -1.20% | 0.91% | -0.97% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.32 | -1.82 | -2.20 | -2.19 | NA |
Estimate | -1.64 | -2.04 | -2.39 | -2.58 | NA |
Difference | 0.32 | 0.22 | 0.19 | 0.39 | 0.28 |
Surprise | 19.51% | 10.78% | 7.95% | 15.12% | 13.34% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more